Status:
RECRUITING
AF Ablation With High Power Short Duration RF
Lead Sponsor:
Clinica Mediterranea
Conditions:
Atrial Fibrillation
Catheter Ablation
Eligibility:
All Genders
18-80 years
Brief Summary
This is a prospective, multi-center, research study designed to evaluate the safety and efficacy of pulmonary vein (PV) isolation with high power short duration radiofrequency energy in patients with ...
Detailed Description
Patients will be screened in ambulatory and scheduled for AF ablation according to current guidelines. Ablation will be usually performed under effective oral anticoagulation. Anticoagulation could be...
Eligibility Criteria
Inclusion Criteria:
- Patients with paroxysmal/persistent AF who signed the informed consent
- Patients on active oral anticoagulation
Exclusion Criteria:
- Previous ablation for AF
- Patients with LVEF<35%
- Women potentially pregnant
- Contraindications to X-ray exposure
- Congenital heart disease or cardiac surgery within 1 month
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
850 Patients enrolled
Trial Details
Trial ID
NCT05777551
Start Date
January 1 2023
End Date
December 31 2027
Last Update
March 5 2024
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Cardiologique Du Nord
Paris, France
2
Clinica Montevergine
Mercogliano, AV, Italy
3
Maria cecilia Hospital
Cotignola, RA, Italy
4
Ospedale di Conegliano
Conegliano, TV, Italy